Feeds

Aussie smoko-proofing drug prevents ill effects of cigs

Well, most of them

Build a business case: developing custom apps

Australian boffins have developed a treatment which allows mice to smoke cigarettes without the usual negative health consequences. The method could potentially allow gasper-loving humans to sidestep some of the self-destructive results of their habit.

The key to the business, according to lead cig-boffin Ross Vlahos, is Granulocyte macrophage-colony stimulating factor (GM-CSF), an agent released by the lungs when they are exposed to cigarette smoke. GM-CSF causes inflammatory leukocytes to activate in the lungs, which then leads to chronic obstructive pulmonary disease (COPD) and other complaints such as "oxidative stress, emphysema, small airway fibrosis, mucus hypersecretion and progressive airflow limitation".

Vlahos and his team at Melbourne uni decided to tackle this by the use of a blocking agent known as "anti GM-CSF". As called for by tradition, they got hold of a group of mice and dosed half of them with the miracle smoko-proofing drug, and left the others alone. Then all the mice were given "the equivalent of nine cigarettes of smoke each day for four days".

At the end of the test every single mouse was dead. However, this was simply because the boffins had killed them in order to examine their lungs. According to the mouse autopsies, the ones treated with "anti GM-CSF" were in much better nick than the others.

"Cigarette smoke-exposed mice that were treated with an anti-GM-CSF had significantly less lung inflammation in comparison to untreated mice," says Vlahos.

"This indicates that GM-CSF is a key mediator in smoke-induced lung inflammation and its neutralization may have therapeutic implications [for humans] in diseases such as COPD."

It would seem then that in future one may be able to take a shot or a pill and then happily puff away on one's little smoky treat, reassured in the knowledge that one's time in the 40-metre dash will be unaffected and the racking, sweaty, grey-faced smoker's cough will not make an appearance.

Unfortunately Anti GM-CSF isn't a cure-all, as the risk of cancer will still remain.

"Our treatment deals with cigarette smoke-induced lung inflammation involved in COPD, not cancer and other smoking-related ailments. Quitting remains the best and only cure for smoking-related lung disease," warns Vlahos sternly.

The smoko-proofing paper, Neutralizing GM-CSF Inhibits Cigarette Smoke-induced Lung Inflammation, is published online by the American Journal of Respiratory and Critical Care Medicine, here. ®

Next gen security for virtualised datacentres

More from The Register

next story
Boffins attempt to prove the UNIVERSE IS JUST A HOLOGRAM
Is this the real life? Is this just fantasy?
China building SUPERSONIC SUBMARINE that travels in a BUBBLE
Shanghai to San Fran in two hours would be a trick, though
Our LOHAN spaceplane ballocket Kickstarter climbs through £8000
Through 25 per cent but more is needed: Get your UNIQUE rewards!
CRR-CRRRK, beep, beep: Mars space truck backs out of slippery sand trap
Curiosity finds new drilling target after course correction
SpaceX prototype rocket EXPLODES over Texas. 'Tricky' biz, says Elon Musk
No injuries or near injuries. Flight stayed in designated area
Galileo, Galileo! Galileo, Galileo! Galileo fit to go. Magnifico
I'm just a poor boy, nobody loves me. But at least I can find my way with ESA GPS by 2017
Astronomers scramble for obs on new comet
Amateur gets fifth confirmed discovery
prev story

Whitepapers

A new approach to endpoint data protection
What is the best way to ensure comprehensive visibility, management, and control of information on both company-owned and employee-owned devices?
Implementing global e-invoicing with guaranteed legal certainty
Explaining the role local tax compliance plays in successful supply chain management and e-business and how leading global brands are addressing this.
Maximize storage efficiency across the enterprise
The HP StoreOnce backup solution offers highly flexible, centrally managed, and highly efficient data protection for any enterprise.
How modern custom applications can spur business growth
Learn how to create, deploy and manage custom applications without consuming or expanding the need for scarce, expensive IT resources.
Next gen security for virtualised datacentres
Legacy security solutions are inefficient due to the architectural differences between physical and virtual environments.